Back to MAVERICK CAPITAL LTD MAVERICK CAPITAL LTD

ALNYALNY
12 quarters

Position history for MAVERICK CAPITAL LTDMAVERICK CAPITAL LTD's holdings in ALNYLAM PHARMACEUTICALS INC

No. Maverick Capital exited its ALNY (Alnylam Pharmaceuticals) position in Q4 2021. Its Q3 2021 13F listed 3,983 shares worth $752,000. Maverick Capital already held ALNY in its Q1 2019 13F, the earliest on record, and held it in 11 quarterly 13F filings.

Final Value

$0

Final Shares

0

Total Value Change

-$300M

Total Shares Change

-3.2M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2021-Q4
Latest
Exited
0
-100.0%
$00.0%$169.58
0
2021-Q3
Decreased
3,983
-98.6%
$752,0000.0%$188.81
0
2021-Q2
Decreased
292,683
-63.2%
$49.6M0.5%$169.52
0
2021-Q1
Decreased
796,234
-19.1%
$112.4M1.0%$141.19
0
2020-Q4
Increased
984,502
+1.8%
$128M2.0%$129.97
53
2020-Q3
Decreased
967,461
-13.1%
$140.9M2.6%$145.60
0
2020-Q2
Decreased
1.1M
-16.9%
$164.9M3.5%$148.11
0
2020-Q1
Decreased
1.3M
-40.7%
$145.8M3.1%$108.85
0
2019-Q4
Decreased
2.3M
-29.9%
$260.4M3.8%$115.17
0
2019-Q3
Decreased
3.2M
-23.9%
$259.2M3.8%$80.42
0
2019-Q2
Increased
4.2M
+31.9%
$307.4M4.5%$72.56
72
2019-Q1
First report
3.2M
-
$300M4.0%$93.45
0

Other major holders of ALNY: BNP PARIBAS FINANCIAL MARKETS, FMR LLC, Capital World Investors

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used